基本信息
views: 49

Bio
Prof. Annalisa Botta’s primary focus is the characterization of human-disease genes (Cystic Fibrosis, Thomsen disease, kidney disease, DiGeorge syndrome, psoriasis, spinal muscular atrophy and myotonic dystrophy). Prof. Botta spent her undergraduate and early postgraduate years studying genetics of Cystic fibrosis, Thomsen disease and DiGeorge syndromes. She continued her work on DiGeorge Syndrome becoming Research Assistant at Baylor College of Medicine in Houston, Texas. She collaborated with Prof. Allan Bradley to develop the first mouse model of DiGeorge syndrome using the Cre-LoxP technology. In 2001 she was funded by Telethon Institute as independent researcher to carry out a two-year project to understand the molecular basis of Di George Syndrome. In 2004, Prof. Botta became Assistant Professor at Tor Vergata University of Rome, Medical Genetic Section. This unit undertakes a broad spectrum of research from the basic mechanisms of genetic diseases to translational projects involving gene therapy strategies and novel diagnostic methods for prenatal diagnosis. Currently, she coordinates the neuromuscular group at the Medical Genetics Section of Tor Vergata University, which is one of the main Italian health care centres for the molecular diagnosis of rare genetic disorders. In this period, she started two lines of research in the neuromuscular disease field: spinal muscular atrophy (SMA) and myotonic dystrophies (DMs). From 2015 to 2018 she has also been employed as a genetic counselor at Tor Vergata Hospital where she had the opportunity develop national National Guidelines for the molecular diagnosis of spinal muscular atrophy and myotonic dystrophy. Her long-term commitment to this field of research is witnessed by the number of peer-review publications on the pathogenetic mechanisms of neuromuscular diseases. Moreover, she has experience in the administration of projects and management of International collaborations being PI and co-PI for numerous grants funded by the Italian Ministry of Research, Italian Ministry of Health, Italian Telethon and AFM. Since 2004, she has been also teaching professor of Medical Genetics courses (both in Italian and English language) in the Faculty of Medicine at Tor Vergata University of Rome.
Research Interests
Papers共 145 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
B. Gasperini, A. Falvino, I. Cariati, R. Bonanni, V. V. Visconti,V. Tancredi,A. Botta,U. Tarantino, S. Grillo
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2024): S180-S180
Cited0Views0Bibtex
0
0
Angela Falvino,Beatrice Gasperini,Ida Cariati,Roberto Bonanni, Angela Chiavoghilefu,Elena Gasbarra,Annalisa Botta,Virginia Tancredi,Umberto Tarantino
Biomedicinesno. 9 (2024): 1948-1948
Laura Serra,Antonio Petrucci,Michela Bruschini,Annalisa Botta, Corrado Campisi,Carlo Caltagirone,Marco Bozzali
NEUROMUSCULAR DISORDERS (2024): 24-30
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2024): S119-S119
Cited0Views0Bibtex
0
0
Angela Falvino,Ida Cariati,Roberto Bonanni,Beatrice Gasperini, Angela Chiavoghilefu,Annalisa Botta,Virginia Tancredi,Umberto Tarantino
International Journal of Bone Fragilityno. 3 (2024): 100-104
International Journal of Molecular Sciencesno. 12 (2023): 10129-10129
Genesno. 3 (2023): 542-542
V. V. Visconti,B. Gasperini,C. Greggi,B. Battistini, A. Messina, M. Renzi, K. Bakhtafrouz,R. Iundusi,A. Botta,L. Palombi,U. Tarantino
Load More
Author Statistics
#Papers: 145
#Citation: 3153
H-Index: 30
G-Index: 52
Sociability: 7
Diversity: 4
Activity: 11
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn